3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Dermatologic
2
Breast
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Sarcoma
16
Central Nervous System Neoplasms
10
Gliosarcoma
9
Glioblastoma
9
Osteosarcoma
8
Astrocytoma
6
Sarcoma, Ewing
5
Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Lung Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Extranodal NK-T-Cell
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia
2
Glioma
2
Esophageal Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Colorectal Neoplasms
2
Interventions
Oxaliplatin
2
Observation
2
Leucovorin
2
Irinotecan
2
Ipilimumab
2
Cisplatin
2
tivozanib
1
spartalizumab
1
seribantumab
1
pembrolizumab
1
motexafin lutetium
1
entinostat
1
atezolizumab
1
Thalidomide
1
Specimen Handling
1
Quality of Life
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Octreotide
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Fluorouracil
1
Floxuridine
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
Drug Therapy
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled